9 key players in the global platelet rich plasma market

The global platelet rich plasma market is expected to hit $400 million by 2023, growing at a 13.3 percent compound annual growth rate, according to a Qurate Business Intelligence report.

Advertisement

The rising geriatric population, which is more prone to orthopedic and neurological diseases, as well as an increasing incidence of sport injuries and orthopedic surgeries are contributing factors to the market growth.

Key players:

1. Zimmer Biomet

2. Stryker

3. DePuy Synthes

4. Isto Biologics

5. Exatech

6. Harvest Technologies

7. Arthrex

8. Regen Lab SA

9. Nuo Therapeutics

More articles on biologics:
3 things to know about the global orthopedic biomaterials market
Bioventus launches biphasic orthopedic, spine bone graft: 3 insights
Biointegrative orthopedic fixation material receives FDA clearance: 5 things to know

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Biologics

Advertisement

Comments are closed.